Literature DB >> 26397896

In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model.

Jessica J Steventon1, David J Harrison2, Rebecca C Trueman2, Anne E Rosser2, Derek K Jones1, Simon P Brooks2.   

Abstract

BACKGROUND: Environmental enrichment has been shown to improve symptoms and reduce neuropathology in mouse models of Huntington's disease (HD); however results are limited to ex vivo techniques with associated shortcomings. In-vivo magnetic resonance imaging (MRI) can overcome some of the shortcomings and is applied for the first time here to assess the effect of a cognitive intervention in a mouse model of HD.
OBJECTIVES: We aimed to investigate whether in-vivo high-field MRI can detect a disease-modifying effect in tissue macrostructure following a cognitive enrichment regime.
METHODS: YAC128 transgenic and wild type mice were exposed to cognitive enrichment throughout their lifetime. At 20-months old, mice were scanned with a T2-weighted MRI sequence and a region-of-interest (ROI) approach was used to examine structural changes. Locomotor activity and performance on the rotarod and serial discrimination watermaze task were assessed to measure motor and cognitive function respectively.
RESULTS: Mice exposed to cognitive enrichment were more active and able to stay on a rotating rod longer compared to control mice, with comparable rotarod performance between HD enriched mice and wild-type mice. YAC128 mice demonstrated cognitive impairments which were not improved by cognitive enrichment. In-vivo MRI revealed a reduction in the degree of caudate-putamen atrophy in the enriched HD mice.
CONCLUSIONS: We provide in vivo evidence of a beneficial effect of environmental enrichment on neuropathology and motor function in a HD mouse model. This demonstrates the efficacy of MRI in a model of HD and provides the basis for an in-vivo non-destructive outcome measure necessary for longitudinal study designs to understand the effect of enrichment with disease progression.

Entities:  

Keywords:  Huntington’s Disease; cognitive enrichment; magnetic resonance imaging; mouse model

Mesh:

Year:  2015        PMID: 26397896      PMCID: PMC7613443          DOI: 10.3233/JHD-150147

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  30 in total

1.  Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Authors:  Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  Implicit learning in a serial choice visual discrimination task in the operant 9-hole box by intact and striatal lesioned mice.

Authors:  Rebecca C Trueman; Simon P Brooks; Stephen B Dunnett
Journal:  Behav Brain Res       Date:  2004-12-30       Impact factor: 3.332

3.  Striatal and white matter predictors of estimated diagnosis for Huntington disease.

Authors:  Jane S Paulsen; Peggy C Nopoulos; Elizabeth Aylward; Christopher A Ross; Hans Johnson; Vincent A Magnotta; Andrew Juhl; Ronald K Pierson; James Mills; Douglas Langbehn; Martha Nance
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

4.  Cerebral cortex structure in prodromal Huntington disease.

Authors:  Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; Hans J Johnson; Vincent A Magnotta; Andrew R Juhl; Ronald K Pierson; James Mills; Douglas R Langbehn; Jane S Paulsen
Journal:  Neurobiol Dis       Date:  2010-08-02       Impact factor: 5.996

5.  Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease.

Authors:  Jeffrey B Carroll; Jason P Lerch; Sonia Franciosi; Amanda Spreeuw; Nagat Bissada; R Mark Henkelman; Michael R Hayden
Journal:  Neurobiol Dis       Date:  2011-03-31       Impact factor: 5.996

6.  In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice.

Authors:  Sarah Biedermann; Johannes Fuss; Lei Zheng; Alexander Sartorius; Claudia Falfán-Melgoza; Traute Demirakca; Peter Gass; Gabriele Ende; Wolfgang Weber-Fahr
Journal:  Neuroimage       Date:  2012-04-12       Impact factor: 6.556

7.  "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease.

Authors:  Nigel I Wood; Dervila Glynn; A Jennifer Morton
Journal:  Neurobiol Dis       Date:  2011-02-13       Impact factor: 5.996

8.  Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.

Authors:  Tara L Spires; Helen E Grote; Neelash K Varshney; Patricia M Cordery; Anton van Dellen; Colin Blakemore; Anthony J Hannan
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.

Authors:  Elizabeth J Slow; Jeremy van Raamsdonk; Daniel Rogers; Sarah H Coleman; Rona K Graham; Yu Deng; Rosemary Oh; Nagat Bissada; Sazzad M Hossain; Yu-Zhou Yang; Xiao-Jiang Li; Elizabeth M Simpson; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

10.  Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HD.

Authors:  Ivan Rattray; Edward Smith; Richard Gale; Kaoru Matsumoto; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more
  1 in total

1.  Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.

Authors:  Jessica J Steventon; Rebecca C Trueman; Da Ma; Emma Yhnell; Zubeyde Bayram-Weston; Marc Modat; Jorge Cardoso; Sebastian Ourselin; Mark Lythgoe; Andrew Stewart; Anne E Rosser; Derek K Jones
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.